Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

SAFEty of Two Strategies of ICD Management at Implantation

Completed

Conditions: Sudden Cardiac Death
Ventricular Fibrillation
Ventricular Flutter

Interventions: Device: Implantable defibrillator

First Posted Date: 2008-04-18

Last Posted Date: 2017-07-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 2120

Registration Number: NCT00661037

Locations: 🇮🇹
Ospedali del Tigullio, via Don Bobbio 25, Lavagna, Italy

A Phase I Evaluation of the Safety of the TriVascular Stent-Graft System in the Treatment of Abdominal Aortic Aneurysms

Phase 1

Completed

Conditions: Abdominal Aortic Aneurysm

Interventions: Device: TriVascular Stent-Graft System

First Posted Date: 2008-03-28

Last Posted Date: 2011-01-28

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 43

Registration Number: NCT00646048

Locations: 🇺🇸
Harbor UCLA Medical Center, Torrance, California, United States
🇺🇸
Georgetown University Pasquerilla Healthcare, Washington, District of Columbia, United States
🇺🇸
University of Florida - Shands Hospital, Gainesville, Florida, United States

and more 4 locations

Longitudinal Surveillance Registry

Terminated

Conditions: Heart Failure
Sudden Cardiac Death

First Posted Date: 2008-03-14

Last Posted Date: 2008-08-18

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 2500

Registration Number: NCT00636272

A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)

Phase 4

Completed

Conditions: Uterine Fibroids
Uterine Neoplasms
Menorrhagia
Leiomyoma
Leiomyomatosis

Interventions: Procedure: Uterine Fibroid Embolization (UFE)
Device: Contour SE™ Microspheres
Device: Embosphere® Microspheres

First Posted Date: 2008-03-05

Last Posted Date: 2012-07-11

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 60

Registration Number: NCT00628901

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Electronic Repositioning With Acuity and Easytrak Leads

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Device: Electronic Repositioning

First Posted Date: 2008-02-07

Last Posted Date: 2021-04-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 305

Registration Number: NCT00610116

Locations: 🇩🇪
University Hospital, Düsseldorf, Germany

The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study

Not Applicable

Completed

Conditions: Post Myocardial Infarction

Interventions: Device: Cardiac pacing using any Guidant/Boston Scientific Implantable ICD or CRT-D System and any Guidant/Boston Scientific Intracardiac Lead System

First Posted Date: 2008-01-31

Last Posted Date: 2017-04-05

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 105

Registration Number: NCT00605631

Locations: 🇺🇸
Christ Hospital, Cincinnati, Ohio, United States

Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Device: Implant of Pressure sensor.

First Posted Date: 2008-01-30

Last Posted Date: 2017-02-17

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 42

Registration Number: NCT00604903

Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™

Phase 3

Completed

Conditions: Transient Ischemic Attack
Thromboembolic Stroke
Stroke Prevention

Interventions: Device: EndoTex™ NexStent™
Device: Filter Wire EZ™

First Posted Date: 2008-01-24

Last Posted Date: 2008-01-24

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 488

Registration Number: NCT00600327

Locations: 🇺🇸
St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
🇺🇸
El Camino Hospital, Mountain View, California, United States
🇺🇸
Hoag Hospital, Newport Beach, California, United States

and more 16 locations

A Prospective, Multi-center, Single Arm Study Evaluating the Express™ Renal Premounted Stent System in the Treatment of Atherosclerotic Lesions in the Aortorenal Ostium.

Phase 4

Completed

Conditions: Atherosclerotic Lesions in the Aortorenal Ostium

Interventions: Device: Express™ Renal Premounted Stent System

First Posted Date: 2008-01-17

Last Posted Date: 2014-11-21

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 100

Registration Number: NCT00597142

Locations: 🇺🇸
Sarasota Memorial Hospital Care System, Sarasota, Florida, United States
🇺🇸
Peoria Radiology Associates Research & Education Foundation, Peoria, Illinois, United States
🇺🇸
Prairie Education & Research Cooperative, Springfield, Illinois, United States

and more 11 locations

Decompensation Detection Study

Completed

Conditions: Heart Failure

First Posted Date: 2007-12-31

Last Posted Date: 2017-02-06

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 699

Registration Number: NCT00583089

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy